Patient Square Capital is set to acquire healthcare firm Premier for $2.6 billion, aiming to enhance its supply chain, technology, and advisory services.
Patient Square Capital, an investment firm focused on healthcare, has announced plans to acquire Premier, a healthcare firm, in a deal valued at approximately $2.6 billion. Under the terms of the agreement, Patient Square will pay $28.25 in cash per share for Premier, representing a premium of 9.7% over the stock’s last closing price on Friday.
Premier collaborates with hospitals, health systems, and various providers to reduce costs and improve patient care by streamlining the procurement of equipment and supplies. Patient Square Capital, on the other hand, specializes in healthcare investments.
Richard Statuto, Chair of Premier’s Board, expressed satisfaction with the agreement, stating, “We are pleased to have reached this agreement and delighted that Patient Square recognizes and is committed to enhancing Premier’s integral role in the U.S. health care system.” He added that the Board unanimously approved the transaction after thorough consideration of various strategic options and consultations with financial and legal advisors. Statuto emphasized that the deal is in the best interests of Premier and its shareholders, offering immediate value while providing the company with access to additional capital to enhance support and services during a critical period in healthcare.
Michael J. Alkire, President and CEO of Premier, highlighted the firm’s achievements since going public in 2013, noting that it has leveraged capital to build expertise in supply chain management, technology, and advisory services. “As the healthcare landscape continues to rapidly evolve, transitioning to private ownership will once again enhance the Company’s financial flexibility and provide additional resources to accelerate the advancement and tech-enablement of our product portfolio,” he stated. Alkire expressed pride in the team’s accomplishments and optimism about future growth and innovation.
Neel Varshney, Founding Partner at Patient Square, remarked, “We have long admired Premier as an innovator of essential services and products to its members, which are leading institutions and providers in the U.S. health care system.” He noted that there is significant potential for Premier to expand its portfolio in supply chain services, data and technology offerings, and consulting solutions that add value to patients. Varshney expressed eagerness to collaborate closely with Premier’s team as they transition to a private company.
The acquisition is anticipated to close by the first quarter of 2026, pending necessary regulatory approvals. Following the completion of the transaction, Premier will operate as a private entity, and its common stock will no longer be listed or traded on public exchanges.
Source: Original article